ITI Pharma and Healthcare Fund Regular-Growth
Equity
Sectoral-Pharma
₹0.32% 1D
NAV on
Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
- Rating
1 - Minimum Investment₹5000
- NAV (Net Asset Value)₹N/A
- AUM (Fund size)₹252 Cr
- Created on1 Nov 2021
Fund Ranking
#15
/ 15 in Sectoral-Pharma
Risk Level
Very High
Very High
Loading...
Returns
Trailing Return
Rolling Return
- 6 Month20.4%
- 1 Year6.6%
- 3 Year (CAGR)18.8%
- All Time (CAGR)13.0%
Category Return
- 6 Month21.5%
- 1 Year13.1%
- 3 Year (CAGR)22.0%
- All Time (CAGR)-
Asset Allocation
- Equity96.8%
- Other3.2%
Top 5 Holdings
Top 5 Sectors
- Apollo Hospitals Enterprise6.25%
- Aurobindo Pharma4.36%
- Linde India1.37%
- Caplin Point Laboratories0.78%
- Cipla1.64%
Fund Information
- Expense Ratio2.69%
- Exit LoadExit load of 0.50%, if redeemed within 3 months.
- Lock-In PeriodNo Lock-In
Managed By
Animesh Singh
May 2026 - Present
Risk & Return Ratio
- Sharpe Ratio
Sharpe Ratio evaluates a fund's return relative to its risk. Higher values signify better risk-adjusted performance. 0.79 - Standard Deviation
Standard deviation measures the volatility of a fund's returns. The higher the value, the riskier the investment. 16.59 - Alpha
Alpha in mutual funds measures excess return relative to a benchmark, indicating a manager's skill at generating returns beyond market performance. -4.40 - Beta
Beta in mutual funds indicates a fund's sensitivity to market changes. A beta over 1 means it's more volatile than the market, while below 1 implies less volatility. 0.98